Invitro Cancer Testing Market
The global market for in vitro diagnostic tests for cancer is predicted to reach nearly $8 billion by the end of 2012, according to a study released by
Kalorama Information of New York. The study, titled “The Worldwide Market for Cancer Diagnostics, 3rd Edition,” notes that the cancer-testing market is being driven by changes in traditional technologies, by the development of novel biomarkers and by new priorities in the clinic.
In addition, the recent trend to treat cancer as a chronic disease is a boon to in vitro diagnostic test makers, according to the study.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024